The recall includes select lots of Up & Up Fragrance-Free Baby Wipes and Up & Up Fresh Cucumber Scented Baby Wipes sold nationwide.

Here is a list of the recalled products including their UPC codes:

Up & Up Fragrance-Free Baby Wipes

• 20 Count: UPC 085239265956
• 72 Count: UPC 085239265949
• 216 Count: UPC 085239265963
• 800 Count: UPC 085239266137
• 1200 Count: UPC 085239266090

Up & Up Fresh Cucumber Scented Baby Wipes

• 72 Count: UPC 085239265970
• 216 Count: UPC 085239265994
• 800 Count: UPC 085239265987

Health Risks and Symptoms

While healthy people may experience mild symptoms such as skin irritation or rashes, Bcc can lead to more serious infections including pneumonia or sepsis in newborns, premature infants and immuno-compromised patients.

Cook Children’s Infectious Diseases specialists encourage families to stop using the recalled wipes immediately and monitor children for symptoms.

“Early warning signs may include redness, tenderness, warmth or swelling on the skin, especially around cuts or abrasions cleaned with the wipes,” said Mary Suzanne Whitworth, M.D., medical director of Infectious Diseases at Cook Children’s. “Infants and young children may also develop fever, poor feeding, irritability or lethargy.”

Families should contact their child’s primary care physician or seek care at one of Cook Children’s Urgent Care Center or Emergency Department if a child develops symptoms or appears ill after exposure to the wipes.

At this time, Cook Children’s infectious disease team has not evaluated any confirmed patient cases linked to the recalled wipes.

What Should Consumers Do?

The FDA advises consumers to stop using the products immediately and return them to any Target store for full refund. More information available on the FDA website.

Miller Queen suffers from a severe and debilitating form of epilepsy known as Dravet syndrome, but you’d never know it by looking at him. At 7 years old, Miller is doing things that never seemed possible like playing soccer and going to school.

“Daily life when you don’t have seizure control is just a rollercoaster,” his mother Chelsea Queen told NBC 5. “You’re kind of always on edge waiting on the next seizure to happen.”

Starting at 6 months old, Miller was having as many as 10 seizures a day. Every treatment he tried failed and his parents were afraid to take their eyes off of him for even a moment.

Then, they found Cook Children’s and M. Scott Perry, M.D.,  an epileptologist and medical director of Neurology and the Genetic Epilepsy Clinic at Cook Children's.

“When you deal with epilepsies that are so difficult to control, it certainly becomes difficult not to feel that there’s not an answer,” Dr. Perry said.

Miller was enrolled in a clinical trial for the drug fenfluramine, which was once used as a popular appetite suppressant. Only a handful of hospitals nationwide were involved in the trial and Cook Children’s happened to be the only one in Texas. The drug completely stopped Miller’s seizures.

“The treatment completely changed his life,” Queen said in the interview with NBC 5. “He’s always been such a happy kid but now he’s able to experience life to the fullest.”

Overall, the clinical trial showed fenfluramine reduced seizures on average by about 70%. The research helped lead to approval from the Federal Drug Administration, opening up fenfluramine as a treatment for everyone with Dravet syndrome.

“The next medication to try and make you seizure-free is probably 2%, but you know what, you might be that 2% so that’s why we keep looking for it,” Perry said.

For Miller’s parents, they know this to be true.

Matt Queen, Miller’s father told NBC 5 “If something doesn’t work, don’t lose hope.”

Sounds fun, right?

But the U.S. Food and Drug Administration has sent out an alert of the “potential for serious injury from eating, drinking, or handling products prepared by adding liquid nitrogen at the point of sale, immediately before consumption.”

If you aren’t familiar with the product’s names, you’ve probably seen them at malls, food courts, kiosks, state or local fairs, and other food retailers. They are food and drinks prepared by adding liquid nitrogen immediately before consumption. The products may include liquid nitrogen-infused colorful cereal or cheese puffs that releases a misty or smoke-like vapor.

The concern is that the liquid nitrogen, although non-toxic, can cause severe damage to skin and internal organs if mishandled or accidently ingested due to the extremely low temperatures it can maintain. The alert from the FDA advises consumers to avoid eating, drinking or handling foods prepared using liquid nitrogen at point of sale and immediately before consumption, due to injury.

A particular worry is for people asthma patients. The FDA says “inhaling the vapor released by a food or drink prepared by adding liquid nitrogen immediately before consumption may also cause breathing difficulty.”

The FDA stated that the organization is aware of severe – and in some cases, life-threatening – injuries, such as damage to skin and internal organs caused by liquid nitrogen still present in the food or drink.

Karen Schultz, M.D., medical director of Pulmonology at Cook Children’s, said this warning is definitely a concern for young asthma patients.

“Inhaling cold air is a known trigger for asthma and, in fact, is used to help determine if someone has asthma (called a ‘cold air challenge’)," Dr. Schultz said.

Worsening signs of asthma include breathing that is hard and fast, trouble talking or walking, inability to work or play, constant coughing, or a color change in the lips and/or nail beds. At this point, rescue medications should be given and the family should seek immediate care.

"General signs of initial worsening of asthma include some difficulty breathing, coughing and wheezing, problems working or playing, or waking up at night coughing," Dr. Schultz said. "At this point families should start using their rescue medications as instructed by their physician. Families should call their physician if their child has required three extra treatments in a 24 hour periods or they need them more frequently than every four hours."

Consumers who have experienced an injury because of handling or eating products prepared with liquid nitrogen at the point of sale, immediately before consumption, should consult their healthcare professional. Consumers should also consider reporting their injury to MedWatch. The FDA encourages consumers with questions about food safety to Submit An Inquiry, or to visit www.fda.gov/fcic for additional information.

* Photo Courtesy of the Food and Drug Administration. Read Alert from FDA.

Related Articles

• Cook Children's Pulmonology
• Appointments and Referrals
• Asthma Information
• What Is an Asthma Emergency?
• Innovative Program Keeps Kids with Asthma in Class and out of the ER
• 'My Child Can't Play Sports. He Has Asthma.'

The FDA's lab found inconsist ammounts of belladona, "a toxic substance, in certain homepathic teething tablets, sometimes far exceeding the amount claimed on the label." The agency warns that homepathic teething tablets containing belladonna pose an unnecessary risk to infants and children and urgests consumers not to use the products. 

The FDA contacted Standard Homeopathic Company, the manufacturer of Hyland's homeopathic teething products, to ask for a recall of its homeopathic teething tablets products labeled as containing belledaonna for protection of the users. So far, the company hasn't agreed to a recall, but the FDA is asking parents to stop using these products. 

Homeopathic teething products have not been evaluated or approved by the FDA for safety or effectiveness. The agency is unaware of any proven health benefit of the products, which are labeled to relieve teething symptoms in children. InSeptember 2016, the FDA warned against the use of these products after receiving adverse event reports.

Last year, Buzzfeed News reported that the agency had examined more than 400 adverse event reports and 10 deaths connected to homeopathic products in the last six years.

Please seek medical care immediately, if your child experiences seizures, difficulity breathing, lethargy, excessive sleepineess, muscle weakness, skin flushing, constipation, difficulty urinating or agitation after using homeopathic teething products.

Homeopathic teething products are labeled to treat the pain or irritability associated with teething, however no study has verified their effectiveness. The FDA has previously recalled teething tabs because they contained an inconsistent amount of belladonna. This is important because even small amounts of belladonna could be toxic, even deadly in a child.

Homeopathic medicines are made by taking a potentially active ingredient, such as belladonna, and diluting it thousands and thousands and thousands of times. For instance, the amount of belladonna in a commercially available teething tab is supposed to be: 0.0000000000002mg of Belladonna alkaloids. If you are thinking, “How could that small amount of anything actually do ANYTHING?” You would be right. Those who prescribe, make or sell homeopathic products claim that despite the dilution, the solution continues to maintain an imprint or memory of the original substance. This statement goes against anything that we know about science (or basic common sense for that matter).

So, why are parents still using them? Because babies get fussy and it’s hard and it causes anxiety and you want to fix it. But, can we be sure that teething actually causes any predictable symptoms? It’s difficult to say. Some studies suggest there might be a day or two of fussiness around the time of tooth eruption, but the idea that babies are fussy for months because of teething has not been found to be true. This is one of many teething myths that are out there.

Treating teething symptoms (even if they are real) probably doesn’t work and many teething treatments can cause dangerous side effects … teething gels with benzocaine can cause your baby to turn blue and amber teething necklaces have no plausible explanation for how they might work and could post a strangulation or choking risk. Even treating with acetaminophen or ibuprofen is not risk free.

If you have given teething tabs and notice any side effects such as those mentioned by the FDA report, call your pediatrician immediately. Watch for seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating or agitation.

If you suspect your baby has teething pain, allow them to chew on their hand or on hard objects for comfort.

No other treatment is required.

About the author

Justin Smith is a pediatrician and the Medical Advisor for Digital Health for Cook Children's in Ft. Worth, Texas. He has an active community on both Facebook and Twitter as @TheDocSmitty and writes weekly for Cook Children's checkupnewsroom.com. His interest in communications started when he realized that his parents were relying more on the internet for medical information. He believes that strategic use of social media and technology by pediatricians to connect with families can deepen their relationship and provide a new level of convenience for both of their busy lifestyles. Dr. Smith’s innovative pediatric clinic, a pediatric clinic “designed by you,” is set to open in Trophy Club in the fall of 2016.

Dr. Vivek H. Murthy said e-cigarettes are the most commonly used form of tobacco among young people in the United States, surpassing conventional tobacco products, including cigarettes, cigars, chewing tobacco and hookahs.

From 2011 to 2015, e-cigarette use among high school students increased 900 percent.

"Compared with older adults, the brain of youth and young adults is more vulnerable to the negative consequences of nicotine exposure," Dr.. Murthy said. 

During the press conference, Dr. Murthy took the opportunity to introduce a new interactive website to provide the facts on e-cigarette use among young and young adults. 

The site states that 6 of 10 American teens believe that e-cigarettes cause little or only some harm as long as they are used sometimes, but not every day. However, the site says that e-cigarettes pose a "significant -- and avoidable -- health risk to young people in the United States. Besides increasing hte possibility of addiction and long-term harm to brain development and respiratory health, e-cigarettes use is associated with the use of tobacco products that can do even more damage to the body. Even breathing e-cigarette aerosol that someone else has exhaled poses potential health risks.

To learn more about e-cigarettes, we talked to Don Wilson, M.D., an endocrinologist and an Endowed Chair of Cardiovascular Health and Risk Prevention at Cook Children’s.

What do e-cigarettes do?

E-cigarettes are designed to simulate the act of smoking and deliver nicotine without the toxic chemicals produced by burning tobacco. The use of nicotine, however, is highly addictive. Recent research suggested nicotine exposure may also cause the brain to become addicted to other substances. Vapor from some e-cigarettes has also been shown to contain known cancer producing and toxic chemicals, such as diethylene glycol and nitrosamines, as well as small particles of toxic metals. Although not well studied, there is the potential for second hand exposure by others in the environment.

How do e-cigarettes work?

E-cigarettes are smokeless, battery operated devices designed to deliver nicotine mixed with a variety of flavorings (fruit, mint, chocolate, etc.) and other chemicals via an inhaled aerosol. They typically resemble regular tobacco cigarettes, cigars, pipes or everyday items like pins or USB memory sticks.

Most e-cigarettes generally contain three components: a cartridge that contains a liquid solution containing various amounts of nicotine, flavoring and other chemicals, a heating device or vaporizer, and a rechargeable battery. Puffing on the e-cigarette activates the battery powered heating device causing the liquid to vaporize. The vapor is inhaled by the user. E-cigarette vapor may include metals, rubber and ceramics which may be aerosolized and have adverse health effects.

Are e-cigarettes safe?

Although a limited number of studies have been conducted, the safety of e-cigarettes has not thoroughly been evaluated in scientific studies.

Here are a few points to consider:

• Nicotine is highly addictive and has negative effects on brain development from infancy to teens.
• Potential consequences of using e-cigarettes among youth include nicotine addiction, withdrawal and the potential for overdose.
• The use of a variety of flavoring in the liquid solution of e-cigarettes has created concern for accidental ingestion by smaller children.
• With the rapid increase in use of electronic nicotine delivery systems (ENDS), users and nonusers are exposed to the aerosol product. While e-cigarette aerosol may contain fewer toxins than cigarette smoke, studies evaluating whether e-cigarettes are less harmful than cigarettes are inconclusive.

Bottom line: e-cigarettes are often promoted as safer alternatives to cigarette smoking. Although very little is known about their safety, they are increasingly being used by youth and young adults.

What about second hand exposure?

The potential exists for secondhand nicotine and other tobacco-related toxin exposures to others. Studies have shown that e-cigarettes are a source of secondhand exposure to nicotine but not to combustion toxins. Thus, while use of e-cigarettes in indoor environments may involuntarily expose nonsmokers to nicotine, it does not seem to expose them to toxic, tobacco-specific combustion products.

What does the American Academy of Pediatrics recommend?

To protect the health of youth, the American Academy of Pediatrics has made the following recommendations:

• Sales of e-cigarettes to minors (under 18 years of age) should be prohibited.
• Candy and fruit flavored e-cigarettes, which encouraged youth smoking initiation, should be banded.
• To avoid exposing others to potential harm, laws should mandate smoke-free environments which include e-cigarette vapor.
• To prevent poisoning, all e-liquids should be required to be sold in child-proof packaging.

There’s been a lot of progress in type 1 diabetes care in the last five years, and I can only expect more in 2016 and upcoming years. I offer my thoughts on three areas for anticipated progress in type 1 diabetes care.

DRUGS

Insulin has been the mainstay in type 1 diabetes care since its purification and use in 1929. We’ve come a long way from purified animal insulin. We’ve had synthetically produced human insulin now for about 20 years.

Further modifications were made to human insulin creating long and short acting insulin analogs which are used today in basal/bolus insulin plans - considered standard of care in those with type 1 diabetes.

Several new analog insulin, either released or awaiting FDA approval, could be game changers for 2016.

Long-acting insulin activity is currently around 24 hours, but having a longer range of activity may benefit some patients with diabetes. Two new long-acting insulins, Tuojeo and Tresiba, continue working beyond 24 hours and have been approved for use only in adults with type 1 diabetes.

Fast acting insulin is essential at meals to control the rise in blood sugar from carbohydrates eaten. An “ultra-fast” acting insulin faster than the current batch of rapid-acting insulins recently started the review process for approval.

None of the current long or short acting analog insulins are generic. The cost of insulin and other diabetes supplies is a significant ongoing expense. A new “semi-generic” form of the long-acting insulin analog, Lantus, received recent approval.

The release of new analog insulin offers more choices, and research will be essential to see how these insulin can be used in children. Also, the number of insulin and increased choices will hopefully mean lower prices for vital medicine in the future.

DEVICES

Technology continues to move forward in its role helping children and families co-pilot type 1 diabetes.

Continuous glucose monitoring (GGM) continues to move into mainstream as a vital tool giving children and families real-time blood sugar information and better managing the highs and lows in blood sugar.

CGM in the clouds refers to the technology allowing remote monitoring of blood sugars. CGM sensor information is broadcasted via a smart phone to a server where it can be retrieved by using another smart phone or internet connected device. Parents can be hundreds of miles away and still have the comfort of monitoring their child’s blood sugar.

All the major insulin pumps have or will shortly have CGM integration allowing the most efficient use in these two tools together. The ultimate pairing of these tools, the artificial pancreas, continues in development.

The artificial pancreas holds the promise to lessen the work in diabetes care and help children have more stable blood sugars by allowing the insulin pump to use CGM information to make adjustments in insulin delivery.

Recent major funding received from the National Institute of Health and other sources will help fuel continued development and improvement.

Ditching the needles

Needles and sharp things are tough reality in diabetes care. Shots and finger pokes are a daily necessity in diabetes care. There’s been talk about non-invasive, needle-free monitoring in diabetes care for decades, but little progress has been made. Although CGM represents major progress, a needle is still needed to insert the device.

Wouldn’t it be great if monitoring of blood sugars or insulin treatment could be done without needles?

2016 has the potential to move forward in this area.

Inhaled insulin was recently approved for use only in adults with type 1 and type 2 diabetes. Further study is needed to see if inhaled insulin has a safe, effective place in treating children with type 1 diabetes.

Google’s glucose-sensing contact lens is probably the most recognized in the effort of various companies developing blood glucose checking without the stick. An ear sensor is being tested by two different companies.

The hormone glucagon is essential in the body to work against insulin and keep blood sugars up. Glucagon treatment, given as an injection, is an emergency measure used in type 1 diabetes when severe low blood sugars happen.

Nasal glucagon development is progressing and will probably reach the market soon with the promise of one less shot needed in an emergency situation of low blood sugar.

Defeat Diabetes

Removed first part For all of us in the field of endocrinology, defeating diabetes is the ultimate goal. For now though, I think 2016 offers the promise of new technology making those the life of someone with type 1 diabetes easier.

Research is also ongoing in re-creating insulin producing cells for re-implantation in the body which is the ultimate in defeating diabetes for good and what a great story that would be as we look ahead to 2017.

That’s the advice from the Food and Drug Administration and Consumer Reports. The FDA has launched an investigation into the potential risks of spray sunscreen.

The concern is that people, especially children, will breathe in the ingredients of the sunscreen. Consumer Reports followed the report by asking that spray sunscreen “should generally not be used by or on children.”

Justin Smith, M.D., a Cook Children’s pediatrician, understands the thought process of this call to action. Dr. Smith says children with asthma may be at greater risk by breathing in the ingredients in the sunscreen.

"Any aerosol product that forms a spray makes particles small enough to get into the lungs if inhaled,” Dr. Smith said. “For some children, this could cause irritation that could lead to difficulty breathing. It is especially important to be cautious in children with asthma and other problems with their lungs."

For more information click here:

• Dr. Smith’s blog on the importance of sunscreen
• The Consumer Reports tips on sunscreen
• The FDA’s full report